AXL and neoplasm: This suggests that as long as the MAPK pathway is inhibited the increased EDN1 expression “nurtures” the otherwise under‐represented population of AXL‐high cells, which eventually can re‐establish tumour growth in the presence of inhibitor even when pathway re‐activation occurs and EDN1 levels drop again.